| | | | | | |

America’s Overmedicated Children – Vera Sherav

AMERICA’S OVERMEDICATED CHILDREN By Vera Sharav YOUTH and MEDICINES in June 1-3, 2005 KILEN: Consumers Institute for Medicines and Health SWEDEN “Forgotten Children” is an investigative report by Carole Keeton Strayhorn,[1] the Texas Comptroller (2004) who uncovered evidence that 60% of children in the Texas foster care system are being…

America’s Overmedicated Children, Presentation by Vera Sharav, Sweden

“Forgotten Children” is an investigative report by Carole Keeton Strayhorn,[1] the Texas Comptroller (2004) who uncovered evidence that 60% of children in the Texas foster care system are being drugged with powerful psychotropic drugs, most of which have not been tested in or approved for use by children. The Food and Drug Administration (FDA) acknowledges that many of these drugs have serious adverse side effects, both physical and psychological. The Comptroller said she was alarmed that in her review of a single month (November 2003), two powerful antipsychotic drugs — Risperdal and Zyprexa — made up half of the drugs prescribed to foster children in Texas. These two drugs have been approved only for adults for the treatment of psychosis – primarily schizophrenia – yet, she found that children as young as four, were receiving these powerful, mind-altering drugs.

Statement of the AHRP Opposing the SACHRP Children’s Committee Recommendations

THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) www.ahrp.org Proposed Changes to Subpart D Regulations Increase Risks to Children in Non-Therapeutic Research Statement of the AHRP Opposing the SACHRP Children’s Committee Recommendations April 18, 2005 The Alliance for Human Research Protection (AHRP) welcomes the opportunity to respond to the question “What…

Statement of the AHRP Opposing the SACHRP Children’s Committee Recommendations

The Alliance for Human Research Protection (AHRP) welcomes the opportunity to respond to the question “What is the Best Way to Protect Children?”

Our recommendation – which is backed up by evidence that children have suffered harm in medical research – is to significantly limit the discretion of IRBs to approve greater than minimal risk research without direct benefit for the child-subjects under 46.406.

We recommend staying the course in requiring that any such proposed experiment undergo a transparent open evaluation with ample opportunity for public oversight and comment – as required under the provisions of 46.407.

US Marshals Seize Millions of Defective Paxil & Avandamet pills – NYT

US Marshals Seize Millions of Defective Paxil & Avandamet pills_NYT Mon, 7 Mar 2005 The FDA and federal marshals yanked millions of tablets of the antidepressant, Paxil CR (Seroxat, controlled release) and the diabetes drug, Avandamet, off the market because they are defective. The Paxil pills split during manufacturing, and…

Examination of Eli Lilly’s Contentions that the BMJ Prozac Documents were Never Missing and Have No Significance

Peter R. Breggin, M.D. 101 East State Street, No. 112 Ithaca, New York 14850 www.breggin.com Phone: 607 272 5328 Fax: 607 272 5329 January 12, 2005 An Examination of Eli Lilly and Company’s Contentions that the BMJ Prozac Documents were Never Missing and Have No Significance A report by Peter…

Free Academic Drug Tests – NYT Editorial Delivers Fatal Blow to Leaders of Psychiatry

Free Academic Drug Tests – NYT Editorial Delivers Fatal Blow to Leaders of Psychiatry Tue, 30 Nov 2004 Today’s editorial in The New York Times is a follow-up to yesterday’s solid report by Barry Meier, that focused on the culpability of academic researchers and their prestigious medical institutions in undermining…

Govt Prozac study Recommends Mandatory Screening & Drugs – "Overdosed America" – OpEd NYT

Govt Prozac study Recommends MANDATORY Screening & Drugs – “Overdosed America”_OpEd NYT Sun, 19 Sep 2004 FDA’s Review of Safety & Efficacy Concerns in Anti-Depressant Use by Children is the subject of a second Congressional hearing by the House Energy & Commerce Subcommittee on Oversight / Investigations on September 23,…

18% decrease SSRI use in Youth – NYT / Suicide Risk Not New – Globe / Prozac no different

18% decrease SSRI use in Youth – NYT / Suicide Risk Not New – Globe / Prozac no different Tue, 21 Sep 2004 The FDA failed to stop drug manufacturers from flooding the air waves and the scientific literature with false and scientifically invalid claims-based on partial data. “The FDA…

FDA’s Waiting Game Exposes Children to Preventable Risks – 9/04 AHRP Comments to FDA

FDA’s Waiting Game Exposes Children to Preventable Risks Comments by Vera Hassner Sharav President The Alliance for Human Research Protection Submitted to FDA Advisory Committee Psychopharmacological Drugs Advisory Committee and Pediatric Subcommittee Drugs Advisory Committee September 13-14, 2004 Meeting RE: Suicidality Associated with Antidepressant Drug Treatment The Alliance for Human…

Clinical Trials Controversy Spotlights Flawed System – Psychiatric News

Clinical Trials Controversy Spotlights Flawed System – Psychiatric News Mon, 19 Jul 2004 Recent independent analyses of the published and unpublished SSRI antidepressant pediatric data submitted by manufacturers to the FDA reveal not only that a disparity exists between published and unpublished data, but it becomes increasingly clear that the…